Clinical Trials

Squamous Cell Carcinoma of Head and Neck

NCT04834349 2023-09-13

Re-irradiation With NBTXR3 in Combination With Pembrolizumab for the Treatment of Inoperable Locoregional Recurrent Head and Neck Squamous Cell Cancer

Squamous Cell Carcinoma of Head and Neck

NCT04922112 2023-08-02

OSA-HN

Squamous Cell Carcinoma of Head and Neck, Sleep Apnea, Obstructive

NCT04987996 2023-06-06

GR-MD-02 + Pembrolizumab Versus Pembrolizumab Monotherapy in Melanoma and Squamous Cell Head and Neck Cancer Patients

DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Melanoma

NCT01332279 2023-04-04

Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

NCT04941365 2022-12-22

SERPENTINE

BreastDermatologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma

NCT04831450 2022-08-04

Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC)

Squamous Cell Carcinoma of Head and Neck

NCT04849377 2022-07-07

RBD-HPV: Risk-Based De-Intensification for HPV+ HNSCC

Squamous Cell Carcinoma of Head and Neck

NCT04003025 2022-04-20

HNCAX01

Withdrawn

Squamous Cell Carcinoma of Head and Neck

NCT04266470 2022-03-29

Monitoring Blood Flow and Metabolic Activity in Malignant Tissue of Head and Neck Region

Squamous Cell Carcinoma of Head and Neck

NCT05099952 2022-01-12

Sleep and Circadian Rhythm Study in Head and Neck Cancer Patients

Squamous Cell Carcinoma of Head and Neck

NCT04262388 2020-11-17

DOME

Head & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung

NCT02686008 2020-01-13

Pharmacodynamic Study to Assess the Anti-proliferative Activity of the PARP Inhibitor Olaparib in Patients With HPV Positive and HPV Negative HNSCC

Squamous Cell Carcinoma of Head and Neck

NCT03575234 2019-08-28

Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal Cancer

Squamous Cell Carcinoma of Head and Neck

NCT03325465 2019-04-22

Neoadjuvant Pembrolizumab + Epacadostat Prior to Curative Surgical Care for Squamous Cell Carcinoma of the Head and Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03114280 2019-04-08

PICH

Phase 1/2 Withdrawn

Squamous Cell Carcinoma of Head and Neck

NCT02993991 2017-12-29

PRIMED-001

Squamous Cell Carcinoma of Head and Neck

NCT02211027 2017-09-07

Biological Vaccine: Semi-allogeneic Human Fibroblasts (MRC-5) Transfected With DNA

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT01545687 2017-08-08

CD2 Lozenges in Preventing Acute Oral Mucositis in Patients With Head and Neck Cancer Receiving Radiotherapy and Chemotherapy

Phase 3 Withdrawn

Phase EARLY_PHASE1 Withdrawn

Squamous Cell Carcinoma of Head and Neck, Body Weight Changes, Head and Neck Neoplasms, Pain

NCT02593929 2017-06-08

Pharmacodynamic Effects and Predictive Biomarkers With Ruxolitinib in Operable Head and Neck Cancer

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT02649530 2016-09-30

A Phase II Trial Evaluating WNT974 in Patients With Metastatic Head and Neck Squamous Cell Carcinoma

Squamous Cell Carcinoma of Head and Neck

NCT01820312 2016-08-08

A Phase II Study to Evaluate Low-Dose Fractionated Radiotherapy (LDFRT)

BreastCNSGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck

NCT00041171 2016-07-12

Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

Phase 3 Withdrawn

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

NCT02119728 2016-04-21

Photodynamic Therapy With HPPH in Treating Patients With Squamous Cell Carcinoma of the Oral Cavity

Squamous Cell Carcinoma of Head and Neck

NCT01586182 2015-09-04

Stereotactic Boost for Oropharyngeal Squamous Cell Carcinoma

Phase 1/2 Withdrawn

Squamous Cell Carcinoma of Head and Neck

NCT01133262 2015-03-10

Effectiveness in Head and Neck Cancer Detection Using Positron Emission Tomography (PET) Insert Device

Withdrawn

Squamous Cell Carcinoma of Head and Neck

NCT01718223 2014-09-03

Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer